Pilot Study of PACHA Program to Enhance Adherence to Adjuvant Endocrine Therapy Among Breast Cancer Survivors
- Conditions
- Breast NeoplasmsBreast Cancer
- Registration Number
- NCT05887102
- Lead Sponsor
- CHU de Quebec-Universite Laval
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 66
Inclusion Criteria:<br><br>For pharmacies :<br><br> - In the province of Quebec, Canada<br><br> - At least one pharmacist agrees to take charge of the project in their pharmacy<br><br> - At least one women has initiated adjuvant endocrine therapy (AET) in the last 6<br> months in the pharmacy<br><br>For pharmacists :<br><br> - Practicing in a pharmacy in the province of Quebec<br><br> - Provide consent<br><br>For women :<br><br> - 18 years old or older<br><br> - Were diagnosed with a first non-metastatic, hormone-sensitive breast cancer<br><br> - Received and AET prescription for the first time in the last 6 months<br><br> - Are fluent in French<br><br> - Have internet access<br><br> - Provide consent<br><br>Exclusion Criteria:<br><br>For women :<br><br>• Live in a residential facility where AET is not self-managed
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method